Tamarind (Tamarindus indica L.) seed a candidate protein source with potential for combating SARS-CoV-2 infection in obesity
dc.contributor.author | Morais, Ana Heloneida de Araújo | |
dc.contributor.author | Medeiros, Amanda F. de | |
dc.contributor.author | Medeiros, Isaiane | |
dc.contributor.author | Lima, Vanessa C. O. de | |
dc.contributor.author | Luz, Anna B. S. | |
dc.contributor.author | Maciel, Bruna L. L. | |
dc.contributor.author | Passos, Thaís S. | |
dc.contributor.authorID | https://orcid.org/0000-0002-6460-911X | pt_BR |
dc.date.accessioned | 2023-08-01T18:26:56Z | |
dc.date.available | 2023-08-01T18:26:56Z | |
dc.date.issued | 2021 | |
dc.description.resumo | Introduction: Obesity and coronavirus disease (COVID)-19 are overlapping pandemics, and one might worsen the other. Methods: This narrative review discusses one of the primary mechanisms to initiate acute respiratory distress syndrome, uncontrolled systemic inflammation in COVID-19, and presents a potential candidate for adjuvant treatment. Blocking the S protein binding to angiotensin-converting enzyme 2 (ACE-2) and the 3C-like protease (3CL pro) is an effective strategy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Results: Host proteases such as FURIN, trypsin, and transmembrane serine protease 2 (TMPRSS) act in S protein activation. Tamarind trypsin inhibitor (TTI) shows several beneficial effects on the reduction of inflammatory markers (tumor necrosis factor α [TNF-α], leptin) and biochemical parameters (fasting glycemia, triglycerides, and very low-density lipoprotein [VLDL]), in addition to improving pancreatic function and mucosal integrity in an obesity model. TTI may inhibit the action of proteases that collaborate with SARS-CoV-2 infection and the neutro phil activity characteristic of lung injury promoted by the virus. Conclusion: Thus, TTI may contribute to combating two severe overlapping problems with high cost and social complex implications, obesity and COVID-19. | pt_BR |
dc.identifier.citation | MORAIS, A. H. A.; MEDEIROS, A. F. ; MEDEIROS, I. ; LIMA, V. C. O. ; LUZ, A. B. S. ; Maciel B L L ; PASSOS, T. S. Tamarind (Tamarindus indica L.) seed a candidate protein source with Potential for combating SARS-CoV-2 infection in obesity. Drug Target Insights, v. 15, p. 5-12, 2021. | pt_BR |
dc.identifier.doi | 10.33393/dti.2021.2192 | |
dc.identifier.uri | https://repositorio.ufrn.br/handle/123456789/54326 | |
dc.language | en | pt_BR |
dc.publisher | Drug Target Insights | pt_BR |
dc.rights | Attribution-NonCommercial 3.0 Brazil | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/br/ | * |
dc.subject | 3CLpro | pt_BR |
dc.subject | ACE-2 | pt_BR |
dc.subject | COVID-19 | pt_BR |
dc.subject | FURIN | pt_BR |
dc.subject | HNE | pt_BR |
dc.subject | Inflammation | pt_BR |
dc.subject | TMPRSS | pt_BR |
dc.title | Tamarind (Tamarindus indica L.) seed a candidate protein source with potential for combating SARS-CoV-2 infection in obesity | pt_BR |
dc.type | article | pt_BR |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- Tamarind (Tamarindus indica L.)_Morais_2021.pdf
- Tamanho:
- 490.28 KB
- Formato:
- Adobe Portable Document Format
Nenhuma Miniatura disponível
Licença do Pacote
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.45 KB
- Formato:
- Item-specific license agreed upon to submission
Nenhuma Miniatura disponível